NVST
Envista Holdings CorpNYSEHealthcare$25.81+0.00%ClosedMarket Cap: $4.24B
As of 2026-04-06
Valuation
P/E (TTM)
90.29
PEG
0.87
P/B
1.37
P/S
1.56
EV/EBITDA
13.39
DCF Value
$47.86
FCF Yield
5.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
55.0%
Operating Margin
8.5%
Net Margin
1.7%
ROE
1.5%
ROA
0.8%
ROIC
1.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $750.6M | 55.0% | $75.8M | $32.9M | $0.20 | — |
| FY 2025 | $2.72B | 55.0% | $225.7M | $47.0M | $0.28 | — |
| Q3 2025 | $669.9M | 56.0% | $64.8M | $-30.3M | $-0.18 | — |
| Q2 2025 | $682.1M | 54.3% | $50.8M | $26.4M | $0.16 | — |
| Q1 2025 | $616.9M | 54.5% | $39.0M | $18.0M | $0.10 | — |
| Q4 2024 | $652.9M | 57.2% | $46.1M | $1.2M | $0.01 | — |
| FY 2024 | $2.51B | 55.4% | $-1.04B | $-1.12B | $-6.50 | — |
| Q3 2024 | $601.0M | 52.8% | $20.9M | $8.2M | $0.05 | — |
| Q2 2024 | $633.1M | 52.1% | $-1.15B | $-1.15B | $-6.69 | — |
| Q1 2024 | $623.6M | 57.4% | $48.1M | $23.6M | $0.14 | — |
| Q4 2023 | $645.6M | 52.4% | $-202.8M | $-217.4M | $-1.27 | — |
| FY 2023 | $2.57B | 56.5% | $31.5M | $-100.2M | $-0.60 | — |